111 related articles for article (PubMed ID: 23802071)
1. Recruitment of myeloid cells to the tumor microenvironment supports liver metastasis.
Lim SY; Gordon-Weeks AN; Zhao L; Tapmeier TT; Im JH; Cao Y; Beech J; Allen D; Smart S; Muschel RJ
Oncoimmunology; 2013 Mar; 2(3):e23187. PubMed ID: 23802071
[TBL] [Abstract][Full Text] [Related]
2. Recruitment of a myeloid cell subset (CD11b/Gr1 mid) via CCL2/CCR2 promotes the development of colorectal cancer liver metastasis.
Zhao L; Lim SY; Gordon-Weeks AN; Tapmeier TT; Im JH; Cao Y; Beech J; Allen D; Smart S; Muschel RJ
Hepatology; 2013 Feb; 57(2):829-39. PubMed ID: 23081697
[TBL] [Abstract][Full Text] [Related]
3. Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases.
Tabariès S; Ouellet V; Hsu BE; Annis MG; Rose AA; Meunier L; Carmona E; Tam CE; Mes-Masson AM; Siegel PM
Breast Cancer Res; 2015 Mar; 17(1):45. PubMed ID: 25882816
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Immune Microenvironment Between Colon and Liver Metastatic Tissue in Colon Cancer Patients with Liver Metastasis.
Zhou SN; Pan WT; Pan MX; Luo QY; Zhang L; Lin JZ; Zhao YJ; Yan XL; Yuan LP; Zhang YX; Yang DJ; Qiu MZ
Dig Dis Sci; 2021 Feb; 66(2):474-482. PubMed ID: 32193860
[TBL] [Abstract][Full Text] [Related]
5. Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis.
Karlmark KR; Weiskirchen R; Zimmermann HW; Gassler N; Ginhoux F; Weber C; Merad M; Luedde T; Trautwein C; Tacke F
Hepatology; 2009 Jul; 50(1):261-74. PubMed ID: 19554540
[TBL] [Abstract][Full Text] [Related]
6. IL-33 promotes growth and liver metastasis of colorectal cancer in mice by remodeling the tumor microenvironment and inducing angiogenesis.
Zhang Y; Davis C; Shah S; Hughes D; Ryan JC; Altomare D; Peña MM
Mol Carcinog; 2017 Jan; 56(1):272-287. PubMed ID: 27120577
[TBL] [Abstract][Full Text] [Related]
7. Premetastatic soil and prevention of breast cancer brain metastasis.
Liu Y; Kosaka A; Ikeura M; Kohanbash G; Fellows-Mayle W; Snyder LA; Okada H
Neuro Oncol; 2013 Jul; 15(7):891-903. PubMed ID: 23595625
[TBL] [Abstract][Full Text] [Related]
8. CCL2 in the Tumor Microenvironment.
O'Connor T; Heikenwalder M
Adv Exp Med Biol; 2021; 1302():1-14. PubMed ID: 34286437
[TBL] [Abstract][Full Text] [Related]
9. Dahuang Zhechong Pill suppresses colorectal cancer liver metastasis via ameliorating exosomal CCL2 primed pre-metastatic niche.
Chen C; Yao X; Xu Y; Zhang Q; Wang H; Zhao L; Wen G; Liu Y; Jing L; Sun X
J Ethnopharmacol; 2019 Jun; 238():111878. PubMed ID: 30986521
[TBL] [Abstract][Full Text] [Related]
10. Distinct populations of metastases-enabling myeloid cells expand in the liver of mice harboring invasive and preinvasive intra-abdominal tumor.
Connolly MK; Mallen-St Clair J; Bedrosian AS; Malhotra A; Vera V; Ibrahim J; Henning J; Pachter HL; Bar-Sagi D; Frey AB; Miller G
J Leukoc Biol; 2010 Apr; 87(4):713-25. PubMed ID: 20042467
[TBL] [Abstract][Full Text] [Related]
11. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
[TBL] [Abstract][Full Text] [Related]
12. TNF Receptor-2 Facilitates an Immunosuppressive Microenvironment in the Liver to Promote the Colonization and Growth of Hepatic Metastases.
Ham B; Wang N; D'Costa Z; Fernandez MC; Bourdeau F; Auguste P; Illemann M; Eefsen RL; Høyer-Hansen G; Vainer B; Evrard M; Gao ZH; Brodt P
Cancer Res; 2015 Dec; 75(24):5235-47. PubMed ID: 26483205
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow-derived Gr1+ cells can generate a metastasis-resistant microenvironment via induced secretion of thrombospondin-1.
Catena R; Bhattacharya N; El Rayes T; Wang S; Choi H; Gao D; Ryu S; Joshi N; Bielenberg D; Lee SB; Haukaas SA; Gravdal K; Halvorsen OJ; Akslen LA; Watnick RS; Mittal V
Cancer Discov; 2013 May; 3(5):578-89. PubMed ID: 23633432
[TBL] [Abstract][Full Text] [Related]
14. Secreted IL-1α promotes T-cell activation and expansion of CD11b(+) Gr1(+) cells in carbon tetrachloride-induced liver injury in mice.
Lin D; Lei L; Zhang Y; Hu B; Bao G; Liu Y; Song Y; Liu C; Wu Y; Zhao L; Yu X; Liu H
Eur J Immunol; 2015 Jul; 45(7):2084-98. PubMed ID: 25870999
[TBL] [Abstract][Full Text] [Related]
15. Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis.
Hu H; Sun L; Guo C; Liu Q; Zhou Z; Peng L; Pan J; Yu L; Lou J; Yang Z; Zhao P; Ran Y
Clin Cancer Res; 2009 Sep; 15(17):5485-93. PubMed ID: 19706805
[TBL] [Abstract][Full Text] [Related]
16. C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis.
Obstfeld AE; Sugaru E; Thearle M; Francisco AM; Gayet C; Ginsberg HN; Ables EV; Ferrante AW
Diabetes; 2010 Apr; 59(4):916-25. PubMed ID: 20103702
[TBL] [Abstract][Full Text] [Related]
17. Macrophages are more potent immune suppressors ex vivo than immature myeloid-derived suppressor cells induced by metastatic murine mammary carcinomas.
Hamilton MJ; Bosiljcic M; Lepard NE; Halvorsen EC; Ho VW; Banáth JP; Krystal G; Bennewith KL
J Immunol; 2014 Jan; 192(1):512-22. PubMed ID: 24285836
[TBL] [Abstract][Full Text] [Related]
18. Chemokine (C-C motif) ligand 2 engages CCR2+ stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone.
Lu X; Kang Y
J Biol Chem; 2009 Oct; 284(42):29087-96. PubMed ID: 19720836
[TBL] [Abstract][Full Text] [Related]
19. Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model.
Teng KY; Han J; Zhang X; Hsu SH; He S; Wani NA; Barajas JM; Snyder LA; Frankel WL; Caligiuri MA; Jacob ST; Yu J; Ghoshal K
Mol Cancer Ther; 2017 Feb; 16(2):312-322. PubMed ID: 27980102
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of B220
Zhang Z; Huang X; Wang E; Huang Y; Yang R
Oncoimmunology; 2021 Apr; 10(1):1912472. PubMed ID: 33948392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
